A case of anti-NPX-2 antibody-positive dermatomyositis resulting in massive haemothorax with acquired factor XIII deficiency
Authors:
- 18 August 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 8 (1) , 91-94
Abstract
Autoimmune diseases, including dermatomyositis, can be complicated by an acquired autoimmune coagulation factor XIII deficiency, which sometimes results in fatal bleeding. Here, we report the case of a young woman with anti-NPX-2 antibody-positive dermatomyositis who developed massive haemothorax with acquired factor XIII deficiency during treatment, including plasma exchange therapy. Emergency transcatheter arterial embolisation was performed and coagulation factor XIII concentrates (Fibrogammin P® 240 U/day for 5 days) were supplemented. Subsequently, the patient was discharged and managed with oral prednisolone and tacrolimus. Coagulation system test results were followed up regularly and remained within normal limits and the patient progressed without recurrence of bleeding symptoms. Coagulation factor XIII deficiency cannot be assessed without measuring coagulation factor XIII activity because common coagulation-fibrinolytic system test results are not abnormal. The measurement of factor XIII activity should be performed when autoimmune diseases are complicated by unexplained bleeding.Keywords
This publication has 11 references indexed in Scilit:
- Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in JapanJournal of Clinical Medicine, 2022
- Factor XIII DeficiencyHematology/Oncology Clinics of North America, 2021
- Dermatomyositis: Clinical features and pathogenesisJournal of the American Academy of Dermatology, 2020
- Acquired factor XIII deficiency: A reviewTransfusion and Apheresis Science, 2018
- Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patientsBlood Reviews, 2017
- Hemorrhagic Acquired Factor XIII (13) Deficiency and Acquired Hemorrhaphilia 13 RevisitedSeminars in Thrombosis and Hemostasis, 2011
- Theoretical Basis of Pathogenic Substance Removal During PlasmapheresisTherapeutic Apheresis and Dialysis, 2011
- Decreased Factor XIII Activity in a Patient With Subcutaneous Bleeding After Double Filtration PlasmapheresisTherapeutic Apheresis and Dialysis, 2009
- Factor XIII deficiencyHaemophilia, 2008
- Microvascular Deposition of Complement Membrane Attack Complex in DermatomyositisNew England Journal of Medicine, 1986